CRISPR gene-editing technique set to push new boundaries By: MarketWatch August 27, 2019 at 05:06 AM EDT Biotechnology companies are seeking to cure forms of blindness, muscular dystrophy and leukemia. Read More >> Related Stocks: Allergan Plc Crispr Therapeutics Ag Editas Medicine Intellia Thera CS Novartis Ag ADR Spark Therap